Allan-Herndon-Dudley Syndrome
Recently, an initiative led by Hyderabad-based paediatrician brought down rare disease Allan-Herndon-Dudley syndrome (AHDS) drug cost from ₹9 crore to ₹2.5 lakh and made seven children to get the medicine tiratricol free of cost.

About Allan-Herndon-Dudley Syndrome:
- It is also known as MCT8 deficiency.
- It is a rare X-linked genetic disorder that primarily affects males and disrupts brain development and movement.
- Cause: It is caused by mutations in the SLC16A2 gene, which block the thyroid hormone triiodothyronine (T3) from entering nerve cells in the developing brain while leaving excess T3 circulating in the bloodstream.
- Symptoms
- It has weak muscle tone (hypotonia) and underdevelopment of many muscles (muscle hypoplasia).
- As they get older, they usually develop joint deformities called contractures, which restrict the movement of certain joints.
- Abnormal muscle stiffness (spasticity), muscle weakness, and involuntary movements of the arms and legs also limit mobility.
- Treatment: Treatment options range from symptomatic interventions, including botulinum toxin injections, levodopa/carbidopa, assistive devices, functional therapies, rehabilitation to replacement therapies.